Your browser doesn't support javascript.
loading
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles.
Touizer, Emma; Alrubayyi, Aljawharah; Ford, Rosemarie; Hussain, Noshin; Gerber, Pehuén Pereyra; Shum, Hiu-Long; Rees-Spear, Chloe; Muir, Luke; Gea-Mallorquí, Ester; Kopycinski, Jakub; Jankovic, Dylan; Jeffery-Smith, Anna; Pinder, Christopher L; Fox, Thomas A; Williams, Ian; Mullender, Claire; Maan, Irfaan; Waters, Laura; Johnson, Margaret; Madge, Sara; Youle, Michael; Barber, Tristan J; Burns, Fiona; Kinloch, Sabine; Rowland-Jones, Sarah; Gilson, Richard; Matheson, Nicholas J; Morris, Emma; Peppa, Dimitra; McCoy, Laura E.
Afiliación
  • Touizer E; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Alrubayyi A; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Ford R; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Hussain N; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Gerber PP; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Shum HL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Rees-Spear C; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Muir L; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Gea-Mallorquí E; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Kopycinski J; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Jankovic D; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Jeffery-Smith A; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Pinder CL; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Fox TA; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Williams I; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Mullender C; Mortimer Market Centre, Department of HIV, Central and North West London NHS Trust, London, UK.
  • Maan I; Institute for Global Health, University College London, London, UK.
  • Waters L; Mortimer Market Centre, Department of HIV, Central and North West London NHS Trust, London, UK.
  • Johnson M; Institute for Global Health, University College London, London, UK.
  • Madge S; Mortimer Market Centre, Department of HIV, Central and North West London NHS Trust, London, UK.
  • Youle M; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Barber TJ; The Ian Charleson Day Centre, Royal Free Hospital NHS Foundation Trust, London, UK.
  • Burns F; The Ian Charleson Day Centre, Royal Free Hospital NHS Foundation Trust, London, UK.
  • Kinloch S; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
  • Rowland-Jones S; The Ian Charleson Day Centre, Royal Free Hospital NHS Foundation Trust, London, UK.
  • Gilson R; Institute for Global Health, University College London, London, UK.
  • Matheson NJ; The Ian Charleson Day Centre, Royal Free Hospital NHS Foundation Trust, London, UK.
  • Morris E; Institute for Global Health, University College London, London, UK.
  • Peppa D; The Ian Charleson Day Centre, Royal Free Hospital NHS Foundation Trust, London, UK.
  • McCoy LE; Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
iScience ; 26(1): 105862, 2023 Jan 20.
Article en En | MEDLINE | ID: mdl-36590902
We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110) and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all timepoints, PLWH had significantly lower neutralizing antibody (nAb) titers than HIV-negative controls. We also observed a delayed development of neutralization in PLWH that was underpinned by a reduced frequency of spike-specific memory B cells (MBCs). Improved neutralization breadth was seen against the Omicron variant (BA.1) after the third vaccine dose in PLWH but lower nAb responses persisted and were associated with global MBC dysfunction. In contrast, SARS-CoV-2 vaccination induced robust T cell responses that cross-recognized variants in PLWH. Strikingly, individuals with low or absent neutralization had detectable functional T cell responses. These PLWH had reduced numbers of circulating T follicular helper cells and an enriched population of CXCR3+CD127+CD8+T cells after two doses of SARS-CoV-2 vaccination.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article